Your browser doesn't support javascript.
loading
True hermaphroditism with dysgerminoma: A case report.
Chen, Chun-Qiao; Liu, Zheng; Lu, Yu-Song; Pan, Min; Huang, Hui.
Afiliación
  • Chen CQ; The Department of Oncology, People's Hospital of Guilin.
  • Liu Z; The Department of Oncology, Fifth Clinical Medical College.
  • Lu YS; College of Medical Laboratory Science, Guilin Medical University, Guilin, Guangxi, China.
  • Pan M; The Department of Oncology, People's Hospital of Guilin.
  • Huang H; The Department of Oncology, People's Hospital of Guilin.
Medicine (Baltimore) ; 99(22): e20472, 2020 May 29.
Article en En | MEDLINE | ID: mdl-32481455
ABSTRACT

INTRODUCTION:

True hermaphroditism is a rare and usually sporadic disorder. It is defined by the presence of both ovarian and testicular tissues together as ovotestis. PATIENT CONCERNS In this study, we reported a rare true hermaphroditism case with dysgerminoma. A 49-year-old woman developed masses in both inguinal regions for 30 years. Recently 3 months, the patient found that the size of mass in her left inguinal region was significantly increased. DIAGNOSIS After surgical resection, the results of immunohistochemical examination in left mass revealed a dysgerminoma with positive expression of placental alkaline phosphatase and octamer-binding transcription factor 3/4, and right mass was a cryptorchidism. Chromosomal analysis revealed the karyotype 46, XY. Combined immunohistochemical and karyotype analysis, a diagnosis of true hermaphroditism with dysgerminoma was made.

INTERVENTIONS:

Radiotherapy combined with chemotherapy after tumor resection was used to improve her prognosis. Hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate were used to maintain her female characteristics.

OUTCOMES:

The patient underwent hormonal replacement and has been well for 6 months.

CONCLUSION:

The positive expression of placental alkaline phosphatase and octamer-binding transcription factor 3/4 could be 2 diagnosis markers of dysgerminoma. Surgery combined with radiotherapy and chemotherapy could improve the prognosis of dysgerminoma. Moreover, hormone replacement therapy with conjugated estrogen and medroxyprogesterone acetate was very helpful to maintain the female characteristic of patients with true hermaphroditism.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Disgerminoma / Trastornos Ovotesticulares del Desarrollo Sexual Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Ováricas / Disgerminoma / Trastornos Ovotesticulares del Desarrollo Sexual Tipo de estudio: Diagnostic_studies / Prognostic_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Medicine (Baltimore) Año: 2020 Tipo del documento: Article